P. Dolin

First name

P.

Last name

Dolin

Liang, H., Kennedy, C., Manne, S., Lin, J. H., & Dolin, P. (2015). Monitoring for proteinuria in patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2014-000071

View

Korhonen, P., Heintjes, E. M., Williams, R., Hoti, F., Christopher, S., Majak, M., et al. (2016). Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries. Bmj. http://doi.org/10.1136/bmj.i3903

View

Boxall, N., Bennett, D., Hunger, M., Dolin, P., & Thompson, P. L. (2016). Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case-control study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2016-000303

View

Strongman, H., Korhonen, P., Williams, R., Bahmanyar, S., Hoti, F., Christopher, S., et al. (2017). Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2016-000364

View

Liang, H., Manne, S., Shick, J., Lissoos, T., & Dolin, P. (2017). Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom. Medicine (Baltimore). http://doi.org/10.1097/md.0000000000007116

View

Ye, Y., Jiang, B., Manne, S., Moses, P. L., Almansa, C., Bennett, D., et al. (2020). Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut. http://doi.org/10.1136/gutjnl-2020-321277

View